128 related articles for article (PubMed ID: 38423846)
1. Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database.
Pierret C; Mainguy M; Leray E
Rev Neurol (Paris); 2024 May; 180(5):429-437. PubMed ID: 38423846
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
Foulon S; Maura G; Dalichampt M; Alla F; Debouverie M; Moreau T; Weill A
J Neurol; 2017 Jun; 264(6):1185-1192. PubMed ID: 28516332
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
[TBL] [Abstract][Full Text] [Related]
4. [Health status of populations living in French overseas territories in 2012, compared with metropolitan France: An analysis of the national health insurance database].
Filipovic-Pierucci A; Rigault A; Fagot-Campagna A; Tuppin P
Rev Epidemiol Sante Publique; 2016 Jun; 64(3):175-83. PubMed ID: 27238162
[TBL] [Abstract][Full Text] [Related]
5. [The organisation of health care and epidemiology of multiple sclerosis in France].
Debouverie M; Rumbach L; Clavelou P
Rev Neurol (Paris); 2007 Jun; 163(6-7):637-45. PubMed ID: 17607182
[TBL] [Abstract][Full Text] [Related]
6. Estimating the prevalence of depression associated with healthcare use in France using administrative databases.
Filipovic-Pierucci A; Samson S; Fagot JP; Fagot-Campagna A
BMC Psychiatry; 2017 Jan; 17(1):1. PubMed ID: 28049496
[TBL] [Abstract][Full Text] [Related]
7. Regional variations in the prevalence of multiple sclerosis in French farmers.
Vukusic S; Van Bockstael V; Gosselin S; Confavreux C
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):707-9. PubMed ID: 17299020
[TBL] [Abstract][Full Text] [Related]
8. [Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature].
Gallini A; Moisan F; Maura G; Carcaillon-Bentata L; Leray E; Haesebaert J; Bruandet A; Moutengou E; Luciano L; Weill A; Marin B; Gardette V
Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S183-S197. PubMed ID: 28341166
[TBL] [Abstract][Full Text] [Related]
9. National estimate of multiple sclerosis incidence in France (2001-2007).
Fromont A; Binquet C; Sauleau E; Fournel I; Despalins R; Rollot F; Weill A; Clerc L; Bonithon-Kopp C; Moreau T
Mult Scler; 2012 Aug; 18(8):1108-15. PubMed ID: 22298591
[TBL] [Abstract][Full Text] [Related]
10. Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption.
Carriere N; Verloop D; Dupont C; Fontaine V; Tir M; Krystkowiak P; Blanchard A; Defebvre MM; Defebvre L
Rev Neurol (Paris); 2017 Jun; 173(6):396-405. PubMed ID: 28495231
[TBL] [Abstract][Full Text] [Related]
11. [Cost of multiple sclerosis in France].
Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database.
Leleu H; Arlet JB; Habibi A; Etienne-Julan M; Khellaf M; Adjibi Y; Pirenne F; Pitel M; Granghaud A; Sinniah C; De Montalembert M; Galacteros F
PLoS One; 2021; 16(7):e0253986. PubMed ID: 34242255
[TBL] [Abstract][Full Text] [Related]
13. Geographic variations of multiple sclerosis in France.
Fromont A; Binquet C; Sauleau EA; Fournel I; Bellisario A; Adnet J; Weill A; Vukusic S; Confavreux C; Debouverie M; Clerc L; Bonithon-Kopp C; Moreau T
Brain; 2010 Jul; 133(Pt 7):1889-99. PubMed ID: 20551111
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.
Blin P; Dureau-Pournin C; Foubert-Samier A; Grolleau A; Corbillon E; Jové J; Lassalle R; Robinson P; Poutignat N; Droz-Perroteau C; Moore N
Eur J Neurol; 2015 Mar; 22(3):464-71. PubMed ID: 25389031
[TBL] [Abstract][Full Text] [Related]
15. Use of medical administrative data for the surveillance of psychotic disorders in France.
Chan Chee C; Chin F; Ha C; Beltzer N; Bonaldi C
BMC Psychiatry; 2017 Dec; 17(1):386. PubMed ID: 29202735
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of multiple sclerosis in Germany: regional differences and drug prescription in the claims data of the statutory health insurance].
Petersen G; Wittmann R; Arndt V; Göpffarth D
Nervenarzt; 2014 Aug; 85(8):990-8. PubMed ID: 25022894
[TBL] [Abstract][Full Text] [Related]
17. Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.
Meltzer E; Charron O; Wozny J; Onuorah H; Montague A; Kline AC; Largent A; Krause TM; Freeman L
Mult Scler Relat Disord; 2023 Dec; 80():105085. PubMed ID: 37931487
[TBL] [Abstract][Full Text] [Related]
18. Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data.
Ogino M; Shiozawa A; Ota H; Okamoto S; Hiroi S; Kawachi I
Neurodegener Dis Manag; 2018 Apr; 8(2):97-103. PubMed ID: 29694267
[TBL] [Abstract][Full Text] [Related]
19. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
Marrie RA; Yu N; Blanchard J; Leung S; Elliott L
Neurology; 2010 Feb; 74(6):465-71. PubMed ID: 20071664
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis prevalence in the United States commercially insured population.
Dilokthornsakul P; Valuck RJ; Nair KV; Corboy JR; Allen RR; Campbell JD
Neurology; 2016 Mar; 86(11):1014-21. PubMed ID: 26888980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
